跳至主要内容
临床试验/NL-OMON48168
NL-OMON48168已完成不适用

Optimizing timing of glucocorticoid treatment in children with congenital adrenal hyperplasia - The Optimed study

Radboud Universitair Medisch Centrum0 个研究点目标入组 50 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
50

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
2 至 17(—)

入选标准

  • * Children with congenital adrenal hyperplasia due to 21 hydroxylase deficientie
  • * Age between 4 and 18 years
  • * Able to collect saliva

排除标准

  • * Other forms of CAH
  • * Not able to collect saliva
  • * Chronical medication use other than related to CAH

研究者

相似试验

已完成
不适用
To study the effects of 2 standard treatment-timing strategies for glucocorticoïd dosage on androgen concentration in CAH childreCongenital adrenal hyperplasia (AGS)
NL-OMON25245Radboudumc, Department of pediatric endocrinology50
进行中(未招募)
1 期
Avoiding over and undertreatment by optimizing of the timing ofglucocorticoïd treatment in children with cnogenital adrenal hyperplasiaCongenital adrenal hyperplasia (CAH) is a disorder of adrenal steroidsynthesis leading to cortisol deficiency and an increase in androgenproduction.Treatment in children consists of hydrocortisone substitutionthereby also restoring the negative feedback on the pituitary gland andconsequently normalize androgen production. There is still no evidenceabout the best timing of hydrocortisone use: The highest dosage ofhydrocortisone in the morning or the highest dosage at night
EUCTR2018-004802-24-NLRadboud University Nijmegen Medical Centre50
尚未招募
不适用
Evaluation of cumulative steroid doses in adult nephrotic syndrome
CTRI/2021/04/033110Funding applied for
已完成
不适用
Optimal regimens of glucocorticoids tapering for remission induction therapy in patients with severe systemic lupus erythematosus : multi-center randomized open label trialsystemic lupus erythematosus
JPRN-UMIN000035865Juntendo University44
招募中
4 期
Optimal tapering regimens of glucocorticoid for severe SLE: multi-center randomized open label trialsystemic lupus erythematosusSLED008180
JPRN-jRCT1031180196Tamura Naoto100